Anti-Human CD140a Recombinant Antibody (Tovetumab) (CAT#: TAB-878)

Recombinant human monoclonal antibody expressed in CHO binding to human CD140a. Tovetumab is a monoclonal antibody designed for the treatment of cancer

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Formats:
  • Isotype Switching:
  • Fc Engineering:
  • Modalities:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location
Normal Tissue
RNA Expression

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • IgG2 - kappa
  • Species Reactivity
  • Human
  • Applications
  • Suitable for use in IP, IF, FuncS, FC, Neut, ELISA, ICC and most other immunological methods.
  • CAS
  • 1243266-04-7
  • Generic Name
  • Tovetumab
  • MW
  • 144.8 kDa
  • Related Disease
  • Glioblastoma multiforme (GBM)

Product Property

  • Purity
  • Purity >95% by SDS-PAGE.
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • Tovetumab;1243266-04-7;MEDI-575;PDGFRA;platelet-derived growth factor receptor, alpha polypeptide;platelet-derived growth factor receptor alpha;CD140a;PDGFR2;PDGFR-alpha;PDGF-R-alpha;CD140a antigen;PDGFRA/BCR fusion;CD140 antigen-like family member A;plat

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Tovetumab"

Afuco™ Anti-PDGFRA ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-878)
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human monoclonal antibody expressed in CHO binding to human CD140a. It is a monoclonal antibody designed for the treatment of cancer
DrugMonitor™ Anti-Tovetumab Antibody (VS-1224-YC1230)
Tovetumab is an anti-PDGFRa monoclonal antibody designed for treating cancer, studied in trials for glioblastoma multiforme and advanced solid malignancies. The DrugMonitor™ Anti-Tovetumab Antibody (VS-1224-YC1230) is an anti-drug antibody (ADA) against Tovetumab. This drug-based antibody is raised in mice immunized with the Tovetumab. The anti-Tovetumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Tovetumab in samples.

See other products for "PDGFRA"

Select a product category from the dropdown menu below to view related products.
Please select product type
Human Antibody Products Neutralizing Antibody Products Rabbit Monoclonal Antibody Products IgG Antibody Products ScFv Antibody Products Fab Antibody Products ADCC Enhanced Antibody Products

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for TAB-878. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare